TYPE 2 DIABETES LEUKOPAK
Non-insulin dependent diabetes, or Type 2 Diabetes, is characterized by hyperglycemia that is caused by a combination of insulin resistance and the body’s inability to compensate by producing more insulin.
Leukopaks are obtained by a donation process where blood is withdrawn from the donor via leukapheresis utilizing an aphresis machine such as the Spectra Optia. The donor’s white blood cells are selectively collected and the remaining blood is reinfused to the body.
PPA's Type 2 Diabetes leukopaks are obtained by aphresis from donors with Type 2 Diabetes. All of our donors are fully consented and IRB approved.
Products sold or distributed by Physicians Plasma Alliance or PPA Research Group are intended and labeled for "Research Use Only" and are never to be used in humans, human trials or used in a manner inconsistent with "Research Use Only" labeling.